• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Isolation and functional characterization of the heavy and light chains of human tissue-type plasminogen activator.

作者信息

Rijken D C, Groeneveld E

出版信息

J Biol Chem. 1986 Mar 5;261(7):3098-102.

PMID:3081501
Abstract

Two-chain tissue-type plasminogen activator (t-PA), which consists of a heavy chain (Mr congruent to 38,000) and a light chain (Mr congruent to 31,000) connected by a disulfide bridge, was reduced with 2-mercaptoethanol and then air-reoxidized at a low protein concentration and carboxamidomethylated. The two chains were separated by means of zinc chelate-agarose, which was found to bind the light chain selectively. The light chain was fully active on the tripeptide substrate H-D-isoleucyl-L-prolyl-L-arginine p-nitroanilide (S-2288) and partially active on plasminogen. The plasminogen activator activity of the light chain was, in contrast to that of two-chain t-PA, not stimulated by fibrin or fibrinogen fragments. Fibrin-agarose chromatography of radiolabeled chains showed that only the heavy chain bound to fibrin. These results indicate that the active site-containing light chain in t-PA needs the heavy chain for fibrin stimulation of its plasminogen activator activity.

摘要

相似文献

1
Isolation and functional characterization of the heavy and light chains of human tissue-type plasminogen activator.
J Biol Chem. 1986 Mar 5;261(7):3098-102.
2
Characterization of a fusion protein consisting of amino acids 1 to 263 of tissue-type plasminogen activator and amino acids 144 to 411 of urokinase-type plasminogen activator.一种融合蛋白的特性分析,该融合蛋白由组织型纤溶酶原激活剂的第1至263个氨基酸和尿激酶型纤溶酶原激活剂的第144至411个氨基酸组成。
J Biol Chem. 1987 Aug 5;262(22):10855-62.
3
Isolation and preliminary characterisation of active B-chain of recombinant tissue-type plasminogen activator.重组组织型纤溶酶原激活剂活性B链的分离及初步鉴定
Thromb Haemost. 1986 Feb 28;55(1):94-7.
4
Comparison of the effects of fibrinogen and fibrin products and isolated peptide chains on the fibrin-mediated stimulation of plasminogen activation by tissue-type plasminogen activator, and on the fibrin-dependent enhancement of the amidolytic activity of one-chain tissue-type plasminogen activator.纤维蛋白原和纤维蛋白产物以及分离的肽链对纤维蛋白介导的组织型纤溶酶原激活物刺激纤溶酶原激活的影响,以及对单链组织型纤溶酶原激活物酰胺水解活性的纤维蛋白依赖性增强作用的比较。
Biol Chem Hoppe Seyler. 1990 Nov;371(11):1067-75. doi: 10.1515/bchm3.1990.371.2.1067.
5
Functional role of proteolytic cleavage at arginine-275 of human tissue plasminogen activator as assessed by site-directed mutagenesis.通过定点诱变评估人组织纤溶酶原激活剂精氨酸-275位点蛋白水解切割的功能作用。
Biochemistry. 1987 Jan 27;26(2):338-43. doi: 10.1021/bi00376a002.
6
Effect of fibrin-like stimulators on the activation of plasminogen by tissue-type plasminogen activator (t-PA)--studies with active site mutagenized plasminogen and plasmin resistant t-PA.纤维蛋白样刺激物对组织型纤溶酶原激活物(t-PA)激活纤溶酶原的影响——用活性位点诱变的纤溶酶原和纤溶酶抗性t-PA进行的研究
Thromb Haemost. 1990 Aug 13;64(1):61-8.
7
Characterization of a chimeric plasminogen activator consisting of amino acids 1 to 274 of tissue-type plasminogen activator and amino acids 138 to 411 of single-chain urokinase-type plasminogen activator.一种嵌合型纤溶酶原激活剂的特性,该激活剂由组织型纤溶酶原激活剂的1至274个氨基酸和单链尿激酶型纤溶酶原激活剂的138至411个氨基酸组成。
J Biol Chem. 1988 Dec 15;263(35):19083-91.
8
Variants of human tissue-type plasminogen activator. Fibrin binding, fibrinolytic, and fibrinogenolytic characterization of genetic variants lacking the fibronectin finger-like and/or the epidermal growth factor domains.人组织型纤溶酶原激活剂的变体。缺乏纤连蛋白指状结构域和/或表皮生长因子结构域的基因变体的纤维蛋白结合、纤维蛋白溶解和纤维蛋白原溶解特性。
J Biol Chem. 1988 Jan 15;263(2):1023-9.
9
Characterization of functional domains in human tissue-type plasminogen activator with the use of monoclonal antibodies.利用单克隆抗体对人组织型纤溶酶原激活剂功能结构域的表征
Eur J Biochem. 1986 Jul 1;158(1):173-7. doi: 10.1111/j.1432-1033.1986.tb09735.x.
10
Characterization of a recombinant fusion protein of the finger domain of tissue-type plasminogen activator with a truncated single chain urokinase-type plasminogen activator.组织型纤溶酶原激活剂手指结构域与截短的单链尿激酶型纤溶酶原激活剂的重组融合蛋白的特性分析
J Biol Chem. 1987 Aug 25;262(24):11779-84.

引用本文的文献

1
Fibrinolytic Enzymes for Thrombolytic Therapy.纤维蛋白溶解酶用于溶栓治疗。
Adv Exp Med Biol. 2019;1148:345-381. doi: 10.1007/978-981-13-7709-9_15.
2
Tissue-type plasminogen activator as a therapeutic target in stroke.组织型纤溶酶原激活剂作为中风的治疗靶点。
Expert Opin Ther Targets. 2008 Feb;12(2):159-70. doi: 10.1517/14728222.12.2.159.
3
Different Effects of Lipopolysaccharide on Plasminogen Activator Inhibitor-1 Production in Aortic Media in Vivo and in Culture.脂多糖对体内及培养的主动脉中膜纤溶酶原激活物抑制剂-1产生的不同影响
J Thromb Thrombolysis. 1996;3(3):215-223. doi: 10.1007/BF00181664.
4
Binding of tissue plasminogen activator to cultured human endothelial cells.组织型纤溶酶原激活剂与培养的人内皮细胞的结合。
J Clin Invest. 1987 Dec;80(6):1712-9. doi: 10.1172/JCI113262.
5
Clearance of the heavy and light polypeptide chains of human tissue-type plasminogen activator in rats.人组织型纤溶酶原激活剂重链和轻链多肽链在大鼠体内的清除率
Biochem J. 1986 Sep 15;238(3):643-6. doi: 10.1042/bj2380643.
6
Involvement of finger domain and kringle 2 domain of tissue-type plasminogen activator in fibrin binding and stimulation of activity by fibrin.组织型纤溶酶原激活物的指状结构域和kringle 2结构域参与纤维蛋白结合及纤维蛋白对其活性的刺激作用。
EMBO J. 1986 Dec 20;5(13):3525-30. doi: 10.1002/j.1460-2075.1986.tb04678.x.